Plasma Cell Neoplasms: Providing a Continuum of Care

Lunch Symposium / 2019 SH/EAHP Workshop

This symposium is not part of the official SH Workshop education program and is planned solely by Mayo Clinic Laboratories.

Thursday, September 12, 2019
Phoenix, Arizona


With continuous advancements in the diagnosis and prognosis of plasma cell neoplasms, it can be challenging for health care providers to keep up. Designed for practicing hematologists and hematopathologists, this program will provide an overview of the evolving repertoire of test options and illustrate how unnecessary, redundant, and costly laboratory tests can be eliminated using data-driven testing algorithms. Armed with this knowledge, health care providers can more effectively diagnose, monitor, and treat patients.

Intended Audience

Hematopathologists and pathologists who provide care for patients with plasma cell neoplasms.


Conference Objectives

Upon completion of the conference, participants should be able to:

  • Describe recent advances in the diagnosis and treatment of plasma cell neoplasms
  • Discuss the approach to test ordering using an algorithmic strategy
  • Review the minimal residual testing in patient care modules
  • Discuss the role of new technology in plasma cell neoplasms

Attendance at this Mayo conference does not indicate nor guarantee competence or proficiency in the performance of any procedures that may be discussed or taught in the courses.



Contact the Education Department at 800-533-1710 or 507-284-3156 or email


12:55 p.m. – Lunch
1:10-2:25 p.m. - Presentation

Featured Presenters

Photo of Francis Buadi, M.D.

Francis Buadi, M.D.

Mayo Clinic Transplant Center, Department of Hematology
Mayo Clinic, Rochester, Minnesota

Photo of Dragan Jevremovic, M.D., Ph.D.

Dragan Jevremovic, M.D., Ph.D.

Cell Kinetics Laboratory
Mayo Clinic, Rochester, Minnesota

Photo of David Murray, M.D., Ph.D.

David Murray, M.D., Ph.D.

Protein Immunology Laboratory
Mayo Clinic, Rochester, Minnesota


Accreditation StatementJointly accredited provider of Inter-professional Continuing Education

In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosure

As a provider accredited by ACCME, Mayo Clinic College of Medicine and Science (Mayo Clinic School of Continuous Professional Development) must ensure balance, independence, objectivity, and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.

MCL Education

MCL Education

This post was developed by our Education and Technical Publications Team.